Vacuum-Assisted Breast Biopsy Device Market Size, Share, and Growth Analysis, By Product (Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices), By Type, By Technique, By Applications, By End User, By Region - Industry Forecast 2026-2033

Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 906.84 Million in 2024 and is poised to grow from USD 1012.94 Million in 2025 to USD 2454.75 Million by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).

The vacuum-assisted breast biopsy (VABB) device market is experiencing significant growth, propelled by the increasing prevalence of breast cancer, a major health concern for women globally. VABB offers superior response times compared to traditional diagnostic methods, which enhances its appeal. Its ability to extract substantial tissue samples with a single needle insertion allows for multiple specimens and contributes to more accurate diagnoses, thereby reducing the likelihood of missed cancer cases and histological underestimations. With breast cancer being a leading cause of mortality among women, heightened awareness and governmental initiatives for early detection are expected to further fuel the demand for VABB devices, solidifying their position as a preferred choice in modern breast cancer diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vacuum-Assisted Breast Biopsy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vacuum-Assisted Breast Biopsy Device Market Segments Analysis

Global Vacuum-Assisted Breast Biopsy Device Market is segmented by Product, Type, Technique, Applications, End User and region. Based on Product, the market is segmented into Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Surgical Biopsy Devices and Others. Based on Type, the market is segmented into 9-12G, <9G and >12G. Based on Technique, the market is segmented into Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Others. Based on Applications, the market is segmented into Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Others. Based on End User, the market is segmented into Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vacuum-Assisted Breast Biopsy Device Market

The increasing adoption of vacuum-assisted breast biopsy (VABB) devices over traditional biopsy techniques is primarily due to their ability to obtain multiple contiguous tissue samples efficiently with a single needle insertion. This method not only enhances diagnostic accuracy by significantly lowering cancer miss rates and histological underestimates but also allows for therapeutic removal of benign lesions like fibroadenomas. Additionally, utilizing percutaneous VABB can diminish the necessity for more invasive open surgical biopsies or excisions, leading to reduced operating costs and shorter hospital stays. Collectively, these factors are propelling the growth of the VABB device market globally.

Restraints in the Global Vacuum-Assisted Breast Biopsy Device Market

The Global Vacuum-Assisted Breast Biopsy Device market faces constraints due to the substantial capital investment and operational expenditures associated with the technology. These devices require expensive components such as vacuum generators and specialized biopsy hand-pieces, along with ongoing costs for consumables like needles, tubing, and localizing markers. Consequently, VABB is frequently employed as a secondary biopsy option in various medical facilities, often reserved for situations where earlier methods, such as fine needle aspiration (FNA) or core biopsies, have proven insufficient or yielded conflicting results with imaging studies. This limitation impacts the overall adoption of VABB in clinical practice.

Market Trends of the Global Vacuum-Assisted Breast Biopsy Device Market

The Global Vacuum-Assisted Breast Biopsy Device market is experiencing significant growth, fueled by advancements in minimally invasive technologies and a heightened focus on early breast cancer detection. An expansive research landscape has led to the innovation of more precise diagnostic solutions, garnering strong support from government initiatives aimed at enhancing cancer research infrastructures. This conducive environment not only facilitates the development of sophisticated devices but also encourages collaborative efforts among healthcare professionals and researchers. As healthcare systems increasingly prioritize patient comfort and accurate diagnostics, the demand for vacuum-assisted breast biopsy devices is poised for continued expansion, reflecting broader trends in personalized medicine and early intervention strategies.